The development of the ovarian cancer genome
The most common and lethal ovarian cancer shows only a handful of cancer causing point mutations in each patient’s tumor. Instead, tumors development appears to be dependent on altering the structure of the genome. We propose to use new methods that we developed to understand when changes in the ovarian cancer genome occur and use this knowledge to develop tests for early detection of ovarian tumors and to identify therapies effective against these early tumors.
Patients diagnosed with ovarian cancer
18 - over 18
Healthy Volunteers Needed
Duration of Participation
Up to 60 months (annual questionnaires).
Tara Macey, Ph.D.
Anna Fuller Foundation